Nykode Therapeutics - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider

27 Mar 2025 16:56 CET

Oslo, Norway, March 27, 2025

Norda ASA has today acquired 3,000,000 shares in Nykode Therapeutics ASA at an
average price of NOK 2.1388 per share. Christian Åbyholm is Chairman of the
Board of Norda ASA and is a Member of the Board of Directors and primary insider
in Nykode Therapeutics ASA. Following the transaction NORDA ASA holds 15,996,755
shares in Nykode Therapeutics ASA. For further details, please see the attached
form.

Norda ASA will together with Christian Åbyholm and the Group of companies
Victoria India Fund AS and Caaby AS following the share transaction hold in
total 35,857,225 shares in Nykode Therapeutics ASA, corresponding to approx.
11.0% of the total outstanding shares.

More information:
Access the news on Oslo Bors NewsWeb site

642414_250327 Attachment.pdf